Literature DB >> 29509930

Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.

Justin T Jordan1, Amy E Sanders2, Terri Armstrong3, Tony Asher4, Amy Bennett5, Erin Dunbar6, Nimish Mohile7, P Leia Nghiemphu8, Timothy R Smith9, Douglas E Ney10.   

Abstract

Mesh：

Year:  2018        PMID： 29509930      PMCID： PMC5909638          DOI： 10.1093/neuonc/nox245

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  31 in total

Review 1.  The prethrombotic state in cancer.

Authors:  G Luzzatto; A I Schafer
Journal:  Semin Oncol       Date:  1990-04       Impact factor: 4.929

2.  Early post-operative magnetic resonance imaging in glioblastoma: correlation among radiological findings and overall survival in 60 patients.

Authors:  Carles Majós; Mònica Cos; Sara Castañer; Miguel Gil; Gerard Plans; Anna Lucas; Jordi Bruna; Carles Aguilera
Journal:  Eur Radiol       Date:  2015-07-19       Impact factor: 5.315

3.  PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma.

Authors:  J R Perry; J A Julian; N J Laperriere; W Geerts; G Agnelli; L R Rogers; M G Malkin; R Sawaya; R Baker; A Falanga; S Parpia; T Finch; M N Levine
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

4.  A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors.

Authors:  Michael B Streiff; Xiaobu Ye; Thomas S Kickler; Serena Desideri; Jayesh Jani; Joy Fisher; Stuart A Grossman
Journal:  J Neurooncol       Date:  2015-06-23       Impact factor: 4.130

Review 5.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

6.  Sociodemographic indicators and risk of brain tumours.

Authors:  Peter D Inskip; Robert E Tarone; Elizabeth E Hatch; Timothy C Wilcosky; Howard A Fine; Peter M Black; Jay S Loeffler; William R Shapiro; Robert G Selker; Martha S Linet
Journal:  Int J Epidemiol       Date:  2003-04       Impact factor: 7.196

7.  Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.

Authors:  M T Nurmohamed; A M van Riel; C M Henkens; M M Koopman; G T Que; P d'Azemar; H R Büller; J W ten Cate; J A Hoek; J van der Meer; C van der Heul; A G Turpie; S Haley; A Sicurella; M Gent
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

Review 8.  Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Authors:  Ethan Basch; Amy P Abernethy; C Daniel Mullins; Bryce B Reeve; Mary Lou Smith; Stephen Joel Coons; Jeff Sloan; Keith Wenzel; Cynthia Chauhan; Wayland Eppard; Elizabeth S Frank; Joseph Lipscomb; Stephen A Raymond; Merianne Spencer; Sean Tunis
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

Review 9.  Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature.

Authors:  D L B Schwappach; M Wernli
Journal:  Eur J Cancer Care (Engl)       Date:  2009-08-25       Impact factor: 2.520

10.  Venous thrombosis in cancer patients: insights from the FRONTLINE survey.

Authors:  Ajay K Kakkar; Mark Levine; H M Pinedo; Robert Wolff; John Wong
Journal:  Oncologist       Date:  2003
View more
  1 in total

1.  Unmet needs and recommendations to improve meningioma care through patient, partner, and health care provider input: a mixed-method study.

Authors:  Amir H Zamanipoor Najafabadi; Johannes P M van de Mortel; Daniel J Lobatto; Dieta R Brandsma; Wilco C Peul; Nienke Biermasz; Martin J B Taphoorn; Linda Dirven; Wouter R van Furth
Journal:  Neurooncol Pract       Date:  2019-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.